Our member firm Kyriakides Georgopoulos Law Firm acted as Greek legal counsel to Medtronic in the global spin-off, enabling the successful carve-out and transfer of Medtronic’s diabetes business to the newly established MiniMed Group.
The transaction spanned over a period of eighteen months and culminated in MiniMed’s Nasdaq IPO — one of the largest medtech listings to date — drawing strong investor demand and achieving significant oversubscription.
A dedicated multidisciplinary KG Law Firm team advised across corporate, employment, regulatory and pharmaceutical matters, and supported the transition with the key commercial agreements required for a seamless separation. Baker McKenzie Sydney and London offices acted as global legal counsel.
The KG Law Firm team was led by Partners Konstantinos Vouterakos and Vasileios Douzenis, supported by Katerina Vogka, Associate. Labour & Employment matters were handled by Kelly Papadaki, Counsel, and Ioanna Chanoumi, Senior Associate. Pharma law advice was provided by Irene Kyriakides, Partner, and Aithra Antoniadou, Associate. Competition and FDI aspects were led by Victoria Mertikopoulou, Partner, assisted by Ifigeneia Argyri, Associate.